Jan 13, 2021 / 03:00PM GMT
Christopher Thomas Schott - JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan and very pleased to be introducing Bausch today. From the company, we have Joe Papa, the company's Chairman and CEO; as well as Paul Herendeen, the company's CFO.
As a reminder, after Joe and Paul's presentation, we're going to have a Q&A session. Anyone who wants to ask a question there, can do so through the Ask a Question button that I'm sure one's been using throughout the conference. Obviously, a lot to talk about the story here between the potential separation as well as the 4Q pre-announcement today. So looking forward to the presentation.
And with that, I'm going to turn it over to Joe.
Joseph C. Papa - Bausch Health Companies Inc. - CEO & Chairman
Thank you, Chris. I certainly want to start by wishing everyone a happy new year. I'm delighted to be here even if it's virtually. And more importantly, I want to have a chance to talk about how Bausch Health Care is planning to move forward
Bausch Health Companies Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Feb 10, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers